{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:48:04Z","timestamp":1785383284685,"version":"3.55.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230823-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate an implementation intervention over 2 years to explore experiences and perspectives of multidisciplinary primary care (PC) teams initiating or expanding MOUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This survey-based and ethnographic qualitative study was conducted at 12 geographically and structurally diverse primary care clinics that enrolled in a hybrid effectiveness\u2013implementation study from July 2020 to July 2022 and included PC teams (prescribing clinicians, nonprescribing behavioral health care managers, and consulting psychiatrists). Survey data analysis was conducted from February to April 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Implementation intervention (external practice facilitation) to integrate OUD treatment alongside existing collaborative care for mental health services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-8\">\n                    <jats:title>Measures<\/jats:title>\n                    <jats:p>Data included (1) quantitative surveys of primary care teams that were analyzed descriptively and triangulated with qualitative results and (2) qualitative field notes from ethnographic observation of clinic implementation meetings analyzed using rapid assessment methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-two primary care team members completed the survey (41 female individuals [66%]; 1 [2%] American Indian or Alaskan Native, 4 [7%] Asian, 5 [8%] Black or African American, 5 [8%] Hispanic or Latino, 1 [2%] Native Hawaiian or Other Pacific Islander, and 46 [4%] White individuals), of whom 37 (60%) were between age 25 and 44 years. An analysis of implementation meetings (n\u2009=\u2009362) and survey data identified 4 themes describing multilevel factors associated with PC team provision of MOUD during implementation, with variation in their experience across clinics. Themes characterized challenges with clinical administrative logistics that limited the capacity to provide rapid access to care and patient engagement as well as clinician confidence to discuss aspects of MOUD care with patients. These challenges were associated with conflicting attitudes among PC teams toward expanding MOUD care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230823-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The results of this survey and qualitative study of PC team perspectives suggest that PC teams need flexibility in appointment scheduling and the capacity to effectively engage patients with OUD as well as ongoing training to maintain clinician confidence in the face of evolving opioid-related clinical issues. Future work should address structural challenges associated with workload burden and limited schedule flexibility that hinder MOUD expansion in PC settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.28627","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T11:31:22Z","timestamp":1691753482000},"page":"e2328627","source":"Crossref","is-referenced-by-count":41,"title":["Integrating Opioid Use Disorder Treatment Into Primary Care Settings"],"prefix":"10.1001","volume":"6","author":[{"given":"Elizabeth J.","family":"Austin","sequence":"first","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa S.","family":"Briggs","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Ferro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Barry","sequence":"additional","affiliation":[{"name":"Advancing Integrated Mental Health Solutions Center, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Heald","sequence":"additional","affiliation":[{"name":"Advancing Integrated Mental Health Solutions Center, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Merrill","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Curran","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy Practice and Psychiatry, University of Arkansas for Medical Sciences, Little Rock"},{"name":"Central Arkansas Veterans Health Care System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Fortney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"},{"name":"Advancing Integrated Mental Health Solutions Center, University of Washington, Seattle"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Ratzliff","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"},{"name":"Advancing Integrated Mental Health Solutions Center, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health University of Washington, Seattle"},{"name":"Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research and Development, VA Puget Sound, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"1","key":"zoi230823r2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1377\/hlthaff.2018.05145","article-title":"Trends in buprenorphine prescribing by physician specialty.","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"zoi230823r3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence.","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi230823r4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder: a scoping review.","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi230823r5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11414-018-9616-9","article-title":"Overcoming barriers to adopting and implementing pharmacotherapy: the medication research partnership.","volume":"46","author":"Croff","year":"2019","journal-title":"J Behav Health Serv Res"},{"key":"zoi230823r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108811","article-title":"Primary care physicians\u2019 preparedness to treat opioid use disorder in the United States: a cross-sectional survey.","volume":"225","author":"Foti","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi230823r7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine.","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann Fam Med"},{"key":"zoi230823r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi230823r9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13011-020-00312-3","article-title":"A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.","volume":"15","author":"Haffajee","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"zoi230823r10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.","volume":"54","author":"Andraka-Christou","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"2","key":"zoi230823r11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11606-008-0881-9","article-title":"Integrating buprenorphine treatment into office-based practice: a qualitative study.","volume":"24","author":"Barry","year":"2009","journal-title":"J Gen Intern Med"},{"key":"zoi230823r12","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.22605\/RRH3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural Remote Health"},{"issue":"1","key":"zoi230823r13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12954-021-00572-7","article-title":"Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.","volume":"18","author":"Aronowitz","year":"2021","journal-title":"Harm Reduct J"},{"issue":"1","key":"zoi230823r14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13722-021-00263-5","article-title":"Clinical leaders and providers\u2019 perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs\u2019 facilities.","volume":"16","author":"Hawkins","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"zoi230823r15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13722-021-00218-w","article-title":"Primary Care Opioid Use Disorders Treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.","volume":"16","author":"Campbell","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"zoi230823r16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13722-022-00312-7","article-title":"Expanding access to medications for opioid use disorder through locally-initiated implementation.","volume":"17","author":"Wyse","year":"2022","journal-title":"Addict Sci Clin Pract"},{"issue":"14","key":"zoi230823r17","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1007\/s11606-021-07274-7","article-title":"Advancing pharmacological treatments for opioid use disorder (adapt-oud): an implementation trial in eight veterans health administration facilities.","volume":"37","author":"Hagedorn","year":"2022","journal-title":"J Gen Intern Med"},{"key":"zoi230823r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112532","article-title":"Using formative evaluation methods to improve clinical implementation efforts: description and an example.","volume":"283","author":"Elwy","year":"2020","journal-title":"Psychiatry Res"},{"issue":"Suppl 2","key":"zoi230823r19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s11606-006-0267-9","article-title":"The role of formative evaluation in implementation research and the QUERI experience.","volume":"21","author":"Stetler","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi230823r20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11606-019-05350-7","article-title":"How practice facilitation strategies differ by practice context.","volume":"35","author":"Nguyen","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi230823r21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"zoi230823r22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"8","key":"zoi230823r23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jamasurg.2021.0543","article-title":"AAPOR reporting guidelines for survey studies.","volume":"156","author":"Pitt","year":"2021","journal-title":"JAMA Surg"},{"key":"zoi230823r24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fpubh.2017.00027","article-title":"Enabling continuous quality improvement in practice: the role and contribution of facilitation.","volume":"5","author":"Harvey","year":"2017","journal-title":"Front Public Health"},{"issue":"1","key":"zoi230823r25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11414-020-09709-1","article-title":"Practice facilitation in integrated behavioral health and primary care settings: a scoping review.","volume":"48","author":"Siantz","year":"2021","journal-title":"J Behav Health Serv Res"},{"issue":"2","key":"zoi230823r26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/add.2007.102.issue-2","article-title":"Staff attitudes towards working with drug users: development of the Drug Problems Perceptions Questionnaire.","volume":"102","author":"Watson","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"zoi230823r27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.","volume":"41","author":"Gordon","year":"2020","journal-title":"Subst Abus"},{"key":"zoi230823r29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/publhealth.2019.40.issue-1","article-title":"Innovations in mixed methods evaluations.","volume":"40","author":"Palinkas","year":"2019","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"zoi230823r30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"1","key":"zoi230823r31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1353\/hpu.2022.0019","article-title":"The balance between serving the community and the reality of treating opioid use disorder in rural primary care practices.","volume":"33","author":"Holtrop","year":"2022","journal-title":"J Health Care Poor Underserved"},{"issue":"4","key":"zoi230823r32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/10550887.2022.2035167","article-title":"Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.","volume":"40","author":"Thompson","year":"2022","journal-title":"J Addict Dis"},{"issue":"2","key":"zoi230823r33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7812\/TPP\/21.203","article-title":"Expanding buprenorphine use in primary care: changing the culture.","volume":"26","author":"Leiser","year":"2022","journal-title":"Perm J"},{"key":"zoi230823r34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions.","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"9","key":"zoi230823r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33659","article-title":"Examining access to primary care for people with opioid use disorder in Ontario, Canada: a randomized clinical trial.","volume":"5","author":"Spithoff","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi230823r36","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07975-7","article-title":"Increasing access to buprenorphine for opioid use disorder in primary care: an assessment of provider incentives.","author":"Kelley","journal-title":"J Gen Intern Med"},{"issue":"11","key":"zoi230823r37","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1111\/add.v114.11","article-title":"Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?","volume":"114","author":"Rhee","year":"2019","journal-title":"Addiction"},{"issue":"2","key":"zoi230823r38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/hesr.v57.2","article-title":"Nudging primary care providers to expand the opioid use disorder workforce.","volume":"57","author":"Domino","year":"2022","journal-title":"Health Serv Res"},{"issue":"10","key":"zoi230823r39","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s11606-019-05195-0","article-title":"Early health system experiences with collaborative care (Cocm) billing codes: a qualitative study of leadership and support staff.","volume":"34","author":"Carlo","year":"2019","journal-title":"J Gen Intern Med"},{"key":"zoi230823r28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B0-12-369398-5\/00562-4","volume-title":"Encyclopedia of Social Measurement: Three Volume Set","author":"Beebe","year":"2005"},{"key":"zoi230823r1","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Accessed May 1, 2023. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808209\/austin_2023_oi_230823_1691002554.49877.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T11:31:27Z","timestamp":1691753487000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28627","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1186\/s13722-025-00568-9","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}